Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2255 | 4690 | 43.4 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
262 | 3 | AUTOPHAGY//RESVERATROL//HISTONE DEACETYLASE INHIBITOR | 44558 |
2255 | 2 | RESVERATROL//PTEROSTILBENE//TRANS RESVERATROL | 4690 |
250 | 1 | RESVERATROL//TRANS RESVERATROL//PICEID | 3813 |
16157 | 1 | OLIGOSTILBENES//GNETACEAE//RESVERATROL OLIGOMER | 670 |
28440 | 1 | PTEROSTILBENE//SPHAEROPHYSA SALSULA//3 METHOXY PTEROSTILBENE | 207 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RESVERATROL | authKW | 7046848 | 47% | 49% | 2199 |
2 | PTEROSTILBENE | authKW | 754225 | 3% | 82% | 142 |
3 | TRANS RESVERATROL | authKW | 687073 | 4% | 64% | 166 |
4 | STILBENE | authKW | 432984 | 5% | 26% | 254 |
5 | PICEATANNOL | authKW | 375171 | 2% | 58% | 99 |
6 | PICEID | authKW | 363256 | 2% | 72% | 78 |
7 | OLIGOSTILBENES | authKW | 277700 | 1% | 89% | 48 |
8 | RESVERATROL OLIGOMER | authKW | 196027 | 1% | 94% | 32 |
9 | GNETACEAE | authKW | 183965 | 1% | 91% | 31 |
10 | EPSILON VINIFERIN | authKW | 167362 | 1% | 86% | 30 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 6075 | 11% | 0% | 528 |
2 | Food Science & Technology | 5643 | 13% | 0% | 633 |
3 | Pharmacology & Pharmacy | 4465 | 20% | 0% | 934 |
4 | Nutrition & Dietetics | 2477 | 7% | 0% | 311 |
5 | Chemistry, Applied | 2245 | 7% | 0% | 338 |
6 | Agriculture, Multidisciplinary | 1854 | 5% | 0% | 212 |
7 | Oncology | 1085 | 10% | 0% | 464 |
8 | Integrative & Complementary Medicine | 846 | 2% | 0% | 83 |
9 | Biochemistry & Molecular Biology | 845 | 15% | 0% | 726 |
10 | Plant Sciences | 777 | 7% | 0% | 338 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NUTR OBES GRP | 33460 | 0% | 43% | 12 |
2 | EA 3675 | 33303 | 0% | 32% | 16 |
3 | GRP ETUD SUBST NAT INTERET THER EUT | 31889 | 0% | 70% | 7 |
4 | CHEM NAT DRUGS | 31228 | 0% | 40% | 12 |
5 | EA ST S CELLULAIRE PHYSIOPATHOL STRATEGIES NUTR | 26035 | 0% | 100% | 4 |
6 | CLIN PHARM DIAGNOST | 23560 | 1% | 13% | 27 |
7 | FISIOL FARM | 23243 | 0% | 71% | 5 |
8 | MYCOL BIOTECHNOL VEGETALE | 23134 | 0% | 44% | 8 |
9 | ANAT COMPARED PATHOL | 20827 | 0% | 80% | 4 |
10 | INVEST BIOMED ENFERMEDADES HEPAT CIBEREHD | 20827 | 0% | 80% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR NUTRITION & FOOD RESEARCH | 13432 | 1% | 3% | 68 |
2 | JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY | 7297 | 4% | 1% | 199 |
3 | VITIS | 2971 | 1% | 2% | 25 |
4 | JOURNAL OF NUTRITIONAL BIOCHEMISTRY | 2272 | 1% | 1% | 34 |
5 | AMERICAN JOURNAL OF ENOLOGY AND VITICULTURE | 1932 | 1% | 1% | 26 |
6 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 1826 | 0% | 1% | 23 |
7 | OXIDATIVE MEDICINE AND CELLULAR LONGEVITY | 1660 | 0% | 1% | 21 |
8 | JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH | 1598 | 0% | 1% | 23 |
9 | JOURNAL OF MEDICINAL FOOD | 1440 | 0% | 1% | 21 |
10 | PHYTOCHEMISTRY | 1205 | 1% | 0% | 67 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RESVERATROL | 7046848 | 47% | 49% | 2199 | Search RESVERATROL | Search RESVERATROL |
2 | PTEROSTILBENE | 754225 | 3% | 82% | 142 | Search PTEROSTILBENE | Search PTEROSTILBENE |
3 | TRANS RESVERATROL | 687073 | 4% | 64% | 166 | Search TRANS+RESVERATROL | Search TRANS+RESVERATROL |
4 | STILBENE | 432984 | 5% | 26% | 254 | Search STILBENE | Search STILBENE |
5 | PICEATANNOL | 375171 | 2% | 58% | 99 | Search PICEATANNOL | Search PICEATANNOL |
6 | PICEID | 363256 | 2% | 72% | 78 | Search PICEID | Search PICEID |
7 | OLIGOSTILBENES | 277700 | 1% | 89% | 48 | Search OLIGOSTILBENES | Search OLIGOSTILBENES |
8 | RESVERATROL OLIGOMER | 196027 | 1% | 94% | 32 | Search RESVERATROL+OLIGOMER | Search RESVERATROL+OLIGOMER |
9 | GNETACEAE | 183965 | 1% | 91% | 31 | Search GNETACEAE | Search GNETACEAE |
10 | EPSILON VINIFERIN | 167362 | 1% | 86% | 30 | Search EPSILON+VINIFERIN | Search EPSILON+VINIFERIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AGGARWAL, BB , BHARDWAJ, A , AGGARWAL, RS , SEERAM, NP , SHISHODIA, S , TAKADA, Y , (2004) ROLE OF RESVERATROL IN PREVENTION AND THERAPY OF CANCER: PRECLINICAL AND CLINICAL STUDIES.ANTICANCER RESEARCH. VOL. 24. ISSUE 5A. P. 2783-2840 | 255 | 77% | 768 |
2 | TOME-CARNEIRO, J , LARROSA, M , GONZALEZ-SARRIAS, A , TOMAS-BARBERAN, FA , GARCIA-CONESA, MT , ESPIN, JC , (2013) RESVERATROL AND CLINICAL TRIALS: THE CROSSROAD FROM IN VITRO STUDIES TO HUMAN EVIDENCE.CURRENT PHARMACEUTICAL DESIGN. VOL. 19. ISSUE 34. P. 6064 -6093 | 236 | 77% | 97 |
3 | PARK, EJ , PEZZUTO, JM , (2015) THE PHARMACOLOGY OF RESVERATROL IN ANIMALS AND HUMANS.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1852. ISSUE 6. P. 1071 -1113 | 236 | 67% | 44 |
4 | BAUR, JA , SINCLAIR, DA , (2006) THERAPEUTIC POTENTIAL OF RESVERATROL: THE IN VIVO EVIDENCE.NATURE REVIEWS DRUG DISCOVERY. VOL. 5. ISSUE 6. P. 493-506 | 138 | 64% | 1725 |
5 | HARIKUMAR, KB , AGGARWAL, BB , (2008) RESVERATROL - A MULTITARGETED AGENT FOR AGE-ASSOCIATED CHRONIC DISEASES.CELL CYCLE. VOL. 7. ISSUE 8. P. 1020 -1035 | 175 | 78% | 255 |
6 | NEVES, AR , LUCIO, M , LIMA, JLC , REIS, S , (2012) RESVERATROL IN MEDICINAL CHEMISTRY: A CRITICAL REVIEW OF ITS PHARMACOKINETICS, DRUG-DELIVERY, AND MEMBRANE INTERACTIONS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 11. P. 1663 -1681 | 206 | 65% | 85 |
7 | KEYLOR, MH , MATSUURA, BS , STEPHENSON, CRJ , (2015) CHEMISTRY AND BIOLOGY OF RESVERATROL-DERIVED NATURAL PRODUCTS.CHEMICAL REVIEWS. VOL. 115. ISSUE 17. P. 8976 -9027 | 181 | 69% | 17 |
8 | PEZZUTO, JM , (2008) RESVERATROL AS AN INHIBITOR OF CARCINOGENESIS.PHARMACEUTICAL BIOLOGY. VOL. 46. ISSUE 7-8. P. 443 -573 | 278 | 61% | 31 |
9 | ZORDOKY, BNM , ROBERTSON, IM , DYCK, JRB , (2015) PRECLINICAL AND CLINICAL EVIDENCE FOR THE ROLE OF RESVERATROL IN THE TREATMENT OF CARDIOVASCULAR DISEASES.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1852. ISSUE 6. P. 1155 -1177 | 179 | 60% | 23 |
10 | SAIKO, P , SZAKMARY, A , JAEGER, W , SZEKERES, T , (2008) RESVERATROL AND ITS ANALOGS: DEFENSE AGAINST CANCER, CORONARY DISEASE AND NEURODEGENERATIVE MALADIES OR JUST A FAD?.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 658. ISSUE 1-2. P. 68-94 | 137 | 78% | 226 |
Classes with closest relation at Level 2 |
Rank | Class id | link |
---|---|---|
1 | 2649 | SIRT1//SIRTUINS//SIRT3 |
2 | 261 | ANTHOCYANINS//POLYPHENOLS//PROCYANIDINS |
3 | 2037 | BAICALIN//BAICALEIN//QUERCETIN |
4 | 4088 | ASTILBIN//RHIZOMA SMILACIS GLABRAE//SMILACACEAE |
5 | 2493 | BOND DISSOCIATION ENTHALPY//RUTIN//MORIN |
6 | 2994 | NRF2//KEAP1//ANTIOXIDANT RESPONSE ELEMENT |
7 | 1893 | LEGUMINOSAE//URUSHIOL//MORACEAE |
8 | 2263 | EMODIN//ALOE VERA//ALOE EMODIN |
9 | 1757 | GREEN TEA//CATECHIN//EGCG |
10 | 4029 | DEGUELIN//CYPERUS ROTUNDUS//KRN5500 |